Cargando…
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
INTRODUCTION: The classic psychedelic psilocybin, found in some mushroom species, has received renewed interest in clinical research, showing potential mental health benefits in preliminary trials. Naturalistic use of psilocybin outside of research settings has increased in recent years, though data...
Autores principales: | Nayak, Sandeep M., Jackson, Hillary, Sepeda, Nathan D., Mathai, David S., So, Sara, Yaffe, Abigail, Zaki, Hadi, Brasher, Trey J., Lowe, Matthew X., Jolly, Del R. P., Barrett, Frederick S., Griffiths, Roland R., Strickland, Justin C., Johnson, Matthew W., Jackson, Heather, Garcia-Romeu, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545967/ https://www.ncbi.nlm.nih.gov/pubmed/37795509 http://dx.doi.org/10.3389/fpsyt.2023.1199642 |
Ejemplares similares
-
Efficacy and safety of psilocybin-assisted treatment for major
depressive disorder: Prospective 12-month follow-up
por: Gukasyan, Natalie, et al.
Publicado: (2022) -
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
por: Davis, Alan K., et al.
Publicado: (2020) -
Emotions and brain function are altered up to one month after a single high dose of psilocybin
por: Barrett, Frederick S., et al.
Publicado: (2020) -
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
por: Garcia-Romeu, Albert, et al.
Publicado: (2021) -
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
por: Doss, Manoj K., et al.
Publicado: (2021)